The degree of apoptosis as an immunostimulant for a DNA vaccine against HIV-1 infection

Vaccine

Volumn 25, Issue 3, 2007, Pages 438-445

  Kojima, Yoshitsugu ^a   Jounai, Nao ^a   Takeshita, Fumihiko ^a   Nakazawa, Masatoshi ^a   Okuda, Kentaro ^b   Watabe, Setsuko ^a   Xin, Ke Qin ^a   Okuda, Kenji ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Apoptosis; DNA vaccine; Internal ribosomal entry site

Indexed keywords

CASPASE 3; DNA VACCINE; ENVELOPE PROTEIN; IMMUNOSTIMULATING AGENT;

ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; DRUG EFFICACY; EMBRYO; ENCEPHALOMYOCARDITIS VIRUS; EXPRESSION VECTOR; FEMALE; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOSTIMULATION; INTERNAL RIBOSOME ENTRY SITE; MOUSE; NONHUMAN; PLASMID VECTOR; PRIORITY JOURNAL; PROMOTER REGION; RNA TRANSLATION; VACCINIA VIRUS; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

ADJUVANTS, IMMUNOLOGIC; AIDS VACCINES; ANIMALS; ANTIBODY FORMATION; APOPTOSIS; BLOTTING, WESTERN; CASPASES; CYTOKINES; DNA, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HIV INFECTIONS; HIV-1; IMMUNITY, CELLULAR; LUCIFERASES; LUMINESCENCE; MICE; MICE, INBRED BALB C; PLASMIDS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VACCINES, DNA; VACCINIA; VACCINIA VIRUS; VIRAL ENVELOPE PROTEINS;

EID: 33845232356     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.08.007     Document Type: Article

References (34)

1. Srivastava I.K., and Liu M.A. Gene vaccines. Ann Intern Med 138 7 (2003) 550-559
2. Liu M.A., McClements W., Ulmer J.B., Shiver J., and Donnelly J. Immunization of non-human primates with DNA vaccines. Vaccine 15 8 (1997) 909-912
3. Babiuk L.A., Pontarollo R., Babiuk S., Loehr B., and van Drunen Littel-van den Hurk S. Induction of immune responses by DNA vaccines in large animals. Vaccine 21 7-8 (2003) 649-658
4. Leitner W.W., and Restifo N.P. DNA vaccines and apoptosis: to kill or not to kill?. J Clin Invest 112 1 (2003) 22-24
5. Albert M.L., Sauter B., and Bhardwaj N. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 392 6671 (1998) 86-89
6. Albert M.L., Pearce S.F., Francisco L.M., Sauter B., Roy P., Silverstein R.L., et al. Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J Exp Med 188 7 (1998) 1359-1368
7. Ying H., Zaks T.Z., Wang R.F., Irvine K.R., Kammula U.S., Marincola F.M., et al. Cancer therapy using a self-replicating RNA vaccine. Nat Med 5 7 (1999) 823-827
8. Leitner W.W., Ying H., Driver D.A., Dubensky T.W., and Restifo N.P. Enhancement of tumor-specific immune response with plasmid DNA replicon vectors. Cancer Res 60 1 (2000) 51-55
9. Chattergoon M.A., Kim J.J., Yang J.S., Robinson T.M., Lee D.J., Dentchev T., et al. Targeted antigen delivery to antigen-presenting cells including dendritic cells by engineered Fas-mediated apoptosis. Nat Biotechnol 18 9 (2000) 974-979
10. Sasaki S., Amara R.R., Oran A.E., Smith J.M., and Robinson H.L. Apoptosis-mediated enhancement of DNA-raised immune responses by mutant caspases. Nat Biotechnol 19 6 (2001) 543-547
11. Sasaki S., Xin K.Q., Okudela K., Okuda K., and Ishii N. Immunomodulation by apoptosis-inducing caspases for an influenza DNA vaccine delivered by gene gun. Gene Ther 9 12 (2002) 828-831
12. Racanelli V., Behrens S.E., Aliberti J., and Rehermann B. Dendritic cells transfected with cytopathic self-replicating RNA induce crosspriming of CD8+ T cells and antiviral immunity. Immunity 20 1 (2004) 47-58
13. Kinsey B.M., Marcelli M., Song L., Bhogal B.S., Ittmann M., and Orson F.M. Enhancement of both cellular and humoral responses to genetic immunization by co-administration of an antigen-expressing plasmid and a plasmid encoding the pro-apoptotic protein Bax. J Gene Med 6 4 (2004) 445-454
14. Shiver J.W., Davies M.E., Yasutomi Y., Perry H.C., Freed D.C., Letvin N.L., et al. Anti-HIV env immunities elicited by nucleic acid vaccines. Vaccine 15 8 (1997) 884-887
15. Xin K.Q., Jounai N., Someya K., Honma K., Mizuguchi H., Naganawa S., et al. Prime-boost vaccination with plasmid DNA and a chimeric adenovirus type 5 vector with type 35 fiber induces protective immunity against HIV. Gene Ther 12 24 (2005) 1769-1777
16. Jounai N., Okuda K., Kojima Y., Toda Y., Hamajima K., Ohba K., et al. Contribution of the rev gene to the immunogenicity of DNA vaccines targeting the envelope glycoprotein of HIV. J Gene Med 5 7 (2003) 609-617
17. Sasaki S., Takeshita F., Xin K.Q., Ishii N., and Okuda K. Adjuvant formulations and delivery systems for DNA vaccines. Methods 31 3 (2003) 243-254
18. Colussi P.A., Harvey N.L., Shearwin-Whyatt L.M., and Kumar S. Conversion of procaspase-3 to an autoactivating caspase by fusion to the caspase-2 prodomain. J Biol Chem 273 41 (1998) 26566-26570
19. Colussi P.A., Harvey N.L., and Kumar S. Prodomain-dependent nuclear localization of the caspase-2 (Nedd2) precursor. A novel function for a caspase prodomain. J Biol Chem 273 38 (1998) 24535-24542
20. Staley K., Blaschke A.J., and Chun J. Apoptotic DNA fragmentation is detected by a semiquantitative ligation-mediated PCR of blunt DNA ends. Cell Death Differ 4 1 (1997) 66-75
21. Aramaki Y., Takano S., and Tsuchiya S. Cationic liposomes induce macrophage apoptosis through mitochondrial pathway. Arch Biochem Biophys 392 2 (2001) 245-250
22. Matsumoto Y., Iwamoto Y., Matsushita T., and Ueoka R. Novel mechanism of hybrid liposomes-induced apoptosis in human tumor cells. Int J Cancer 115 3 (2005) 377-382
23. Tsuji T., Hamajima K., Fukushima J., Xin K.Q., Ishii N., Aoki I., et al. Enhancement of cell-mediated immunity against HIV-1 induced by coinnoculation of plasmid-encoded HIV-1 antigen with plasmid expressing IL-12. J Immunol 158 8 (1997) 4008-4013
24. Sasaki S., Sumino K., Hamajima K., Fukushima J., Ishii N., Kawamoto S., et al. Induction of systemic and mucosal immune responses to human immunodeficiency virus type 1 by a DNA vaccine formulated with QS-21 saponin adjuvant via intramuscular and intranasal routes. J Virol 72 6 (1998) 4931-4939
25. Okuda K., Bukawa H., Hamajima K., Kawamoto S., Sekigawa K., Yamada Y., et al. Induction of potent humoral and cell-mediated immune responses following direct injection of DNA encoding the HIV type 1 env and rev gene products. AIDS Res Hum Retroviruses 11 8 (1995) 933-943
26. Kojima Y., Xin K.Q., Ooki T., Hamajima K., Oikawa T., Shinoda K., et al. Adjuvant effect of multi-CpG motifs on an HIV-1 DNA vaccine. Vaccine 20 23-24 (2002) 2857-2865
27. Belyakov I.M., Derby M.A., Ahlers J.D., Kelsall B.L., Earl P., Moss B., et al. Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge. Proc Natl Acad Sci USA 95 4 (1998) 1709-1714
28. Havenga M.J., Vogels R., Braakman E., Kroos N., Valerio D., Hagenbeek A., et al. Second gene expression in bicistronic constructs using short synthetic intercistrons and viral IRES sequences. Gene 222 2 (1998) 319-327
29. Mizuguchi H., Xu Z., Ishii-Watabe A., Uchida E., and Hayakawa T. IRES-dependent second gene expression is significantly lower than cap-dependent first gene expression in a bicistronic vector. Mol Ther 1 4 (2000) 376-382
30. Hennecke M., Kwissa M., Metzger K., Oumard A., Kroger A., Schirmbeck R., et al. Composition and arrangement of genes define the strength of IRES-driven translation in bicistronic mRNAs. Nucleic Acids Res 29 16 (2001) 3327-3334
31. Qiao J., Roy V., Girard M.H., and Caruso M. High translation efficiency is mediated by the encephalomyocarditis virus internal ribosomal entry sites if the natural sequence surrounding the eleventh AUG is retained. Hum Gene Ther 13 7 (2002) 881-887
32. Lu S., Santoro J.C., Fuller D.H., Haynes J.R., and Robinson H.L. Use of DNAs expressing HIV-1 Env and noninfectious HIV-1 particles to raise antibody responses in mice. Virology 209 1 (1995) 147-154
33. Okada E., Sasaki S., Ishii N., Aoki I., Yasuda T., Nishioka K., et al. Intranasal immunization of a DNA vaccine with IL-12-and granulocyte-macrophage colony-stimulating factor (GM-CSF)-expressing plasmids in liposomes induces strong mucosal and cell-mediated immune responses against HIV-1 antigens. J Immunol 159 7 (1997) 3638-3647
34. Richmond J.F., Lu S., Santoro J.C., Weng J., Hu S.L., Montefiori D.C., et al. Studies of the neutralizing activity and avidity of anti-human immunodeficiency virus type 1 Env antibody elicited by DNA priming and protein boosting. J Virol 72 11 (1998) 9092-9100